Christopher Kenneth Savile - Net Worth and Insider Trading

Christopher Kenneth Savile Net Worth

The estimated net worth of Christopher Kenneth Savile is at least $136,231 dollars as of 2024-09-22. Christopher Kenneth Savile is the Director, Senior Officer of Willow Biosciences Inc and owns about 1,362,313 shares of Willow Biosciences Inc (TSX:WLLW) stock worth over $136,231. Details can be seen in Christopher Kenneth Savile's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Kenneth Savile has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher Kenneth Savile

To

Christopher Kenneth Savile Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Kenneth Savile owns 1 companies in total, including Willow Biosciences Inc (TSX:WLLW) .

Click here to see the complete history of Christopher Kenneth Savile’s form 4 insider trades.

Insider Ownership Summary of Christopher Kenneth Savile

Ticker Comapny Transaction Date Type of Owner
TSX:WLLW Willow Biosciences Inc 2024-09-05 Director & Senior Officer

Christopher Kenneth Savile Latest Holdings Summary

Christopher Kenneth Savile currently owns a total of 1 stock. Christopher Kenneth Savile owns 1,362,313 shares of Willow Biosciences Inc (TSX:WLLW) as of September 5, 2024, with a value of $136,231.

Latest Holdings of Christopher Kenneth Savile

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:WLLW Willow Biosciences Inc 2024-09-05 1,362,313 0.10 136,231

Holding Weightings of Christopher Kenneth Savile


Christopher Kenneth Savile Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Kenneth Savile has made a total of 2 transactions in Willow Biosciences Inc (TSX:WLLW) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Willow Biosciences Inc is the acquisition of 50,000 shares on September 5, 2024, which cost Christopher Kenneth Savile around $5,000.

Insider Trading History of Christopher Kenneth Savile

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Kenneth Savile Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Kenneth Savile Ownership Network

Ownership Network List of Christopher Kenneth Savile

No Data

Ownership Network Relation of Christopher Kenneth Savile

Insider Network Chart

Christopher Kenneth Savile Owned Company Details

What does Willow Biosciences Inc do?

Who are the key executives at Willow Biosciences Inc?

Christopher Kenneth Savile is the Director & Senior Officer of Willow Biosciences Inc. Other key executives at Willow Biosciences Inc include Senior Officer Travis Doupe , Director & Senior Officer Trevor Anthony Peters , and Senior Officer Troy Tapan Talkkari .

Willow Biosciences Inc (TSX:WLLW) Insider Trades Summary

Over the past 18 months, Christopher Kenneth Savile made 2 insider transaction in Willow Biosciences Inc (TSX:WLLW) with a net purchase of 38,143. Other recent insider transactions involving Willow Biosciences Inc (TSX:WLLW) include a net purchase of 89,500 shares made by Travis Doupe , a net purchase of 70,000 shares made by Patricia Ranija Choudhary , and a net sale of 14,401 shares made by Barbara Elaine Munroe .

In summary, during the past 3 months, insiders sold 0 shares of Willow Biosciences Inc (TSX:WLLW) in total and bought 99,500 shares, with a net purchase of 99,500 shares. During the past 18 months, 40,659 shares of Willow Biosciences Inc (TSX:WLLW) were sold and 209,500 shares were bought by its insiders, resulting in a net purchase of 168,841 shares.

Willow Biosciences Inc (TSX:WLLW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Willow Biosciences Inc Insider Transactions

No Available Data

Christopher Kenneth Savile Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Kenneth Savile. Currently GuruFocus does not have mailing address information for Christopher Kenneth Savile.

Discussions on Christopher Kenneth Savile

No discussions yet.